Candriam S.C.A. Danaher Corp Transaction History

Candriam S.C.A.

$17.1 Billion
Q3 2024

A detailed history of Candriam S.C.A. transactions in Danaher Corp stock. As of the latest transaction made, Candriam S.C.A. holds 352,267 shares of DHR stock, worth $81.3 Million. This represents 0.57% of its overall portfolio holdings.

Number of Shares

352,267

Previous 409,474 13.97%

Holding current value

$81.3 Million

Previous $102 Million 4.28%

% of portfolio

0.57%

Previous 0.63%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$239.25 - $280.76 $13.7 Million - $16.1 Million	-57,207 Reduced 13.97%	352,267 $97.9 Million
Q2 2024 Aug 05, 2024	SELL	$235.51 - $267.98 $24.5 Million - $27.9 Million	-104,048 Reduced 20.26%	409,474 $102 Million
Q1 2024 May 03, 2024	SELL	$224.58 - $256.19 $25.8 Million - $29.4 Million	-114,792 Reduced 18.27%	513,522 $128 Million
Q4 2023 Feb 14, 2024	BUY	$185.1 - $233.13 $2.39 Million - $3.01 Million	12,921 Added 2.1%	628,314 $145 Million
Q3 2023 Nov 13, 2023	SELL	$233.08 - $265.59 $38.8 Million - $44.3 Million	-166,645 Reduced 21.31%	615,393 $153 Million
Q2 2023 Aug 08, 2023	SELL	$224.99 - $256.14 $35.2 Million - $40.1 Million	-156,652 Reduced 16.69%	782,038 $188 Million
Q1 2023 May 12, 2023	SELL	$239.75 - $277.0 $1.36 Million - $1.57 Million	-5,673 Reduced 0.6%	938,690 $237 Million
Q4 2022 Feb 13, 2023	BUY	$241.42 - $282.29 $14 Million - $16.4 Million	58,101 Added 6.56%	944,363 $251 Million
Q3 2022 Nov 10, 2022	SELL	$247.06 - $1507.4 $637,414 - $3.89 Million	-2,580 Reduced 0.29%	886,262 $229 Million
Q2 2022 Aug 03, 2022	BUY	$237.11 - $299.66 $11.6 Million - $14.6 Million	48,791 Added 5.81%	888,842 $225 Million
Q1 2022 May 13, 2022	SELL	$257.27 - $315.76 $16.2 Million - $19.8 Million	-62,822 Reduced 6.96%	840,051 $246 Million
Q4 2021 Feb 10, 2022	BUY	$292.08 - $329.01 $28.8 Million - $32.4 Million	98,627 Added 12.26%	902,873 $297 Million
Q3 2021 Nov 09, 2021	SELL	$272.21 - $332.43 $15.5 Million - $18.9 Million	-56,901 Reduced 6.61%	804,246 $245 Million
Q2 2021 Jul 20, 2021	BUY	$225.08 - $271.69 $15 Million - $18.1 Million	66,621 Added 8.38%	861,147 $231 Million
Q1 2021 Apr 29, 2021	SELL	$212.38 - $245.9 $849 - $983	-4 Reduced -0.0%	794,526 $170 Million
Q4 2020 Jan 22, 2021	BUY	$212.5 - $245.46 $6.71 Million - $7.75 Million	31,588 Added 4.14%	794,530 $177 Million
Q3 2020 Oct 19, 2020	BUY	$177.16 - $215.33 $29.9 Million - $36.3 Million	168,658 Added 28.38%	762,942 $164 Million
Q2 2020 Jul 23, 2020	BUY	$128.7 - $176.83 $36.1 Million - $49.5 Million	280,120 Added 89.16%	594,284 $105 Million
Q1 2020 May 26, 2020	BUY	$121.39 - $169.05 $8,133 - $11,326	67 Added 0.02%	314,164 $47.1 Million
Q4 2019 Jan 21, 2020	BUY	$133.47 - $153.48 $24.3 Million - $28 Million	182,406 Added 138.51%	314,097 $48,000
Q3 2019 Oct 21, 2019	SELL	$135.4 - $146.47 $7.37 Million - $7.97 Million	-54,407 Reduced 29.24%	131,691 $19,000
Q2 2019 Aug 01, 2019	BUY	$124.88 - $143.73 $1.26 Million - $1.45 Million	10,054 Added 5.71%	186,098 $26.5 Million
Q1 2019 May 02, 2019	SELL	$97.62 - $132.29 $23.6 Million - $31.9 Million	-241,270 Reduced 57.81%	176,044 $23.2 Million
Q4 2018 Feb 14, 2019	SELL	$94.85 - $109.54 $948,974 - $1.1 Million	-10,005 Reduced 2.34%	417,314 $43 Million
Q3 2018 Nov 07, 2018	BUY	$98.13 - $108.9 $28.6 Million - $31.8 Million	291,690 Added 215.06%	427,319 $46.4 Million
Q2 2018 Aug 14, 2018	BUY	$96.1 - $103.24 $7.64 Million - $8.21 Million	79,486 Added 141.58%	135,629 $13.4 Million
Q1 2018 May 09, 2018	BUY	$92.16 - $103.8 $258,877 - $291,574	2,809 Added 5.27%	56,143 $5.5 Million
Q4 2017 Feb 07, 2018	SELL	$85.26 - $94.62 $5.62 Million - $6.23 Million	-65,886 Reduced 55.26%	53,334 $4.95 Million
Q3 2017 Nov 03, 2017	BUY	$79.29 - $88.45 $9.45 Million - $10.5 Million	119,220	119,220 $10.2 Million

Others Institutions Holding DHR

# of Institutions

2,511

Shares Held

539M

Call Options Held

7.07M

Put Options Held

4.55M

View Full List

About DANAHER CORP

Ticker DHR
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 727,963,008
Market Cap $168B
Description
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...

More about DHR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Candriam S.C.A., based on Form 13F filings with the SEC.

News

Stay updated on Candriam S.C.A. with notifications on news.

Account